Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 weeks agoModerna stock sank Friday after the Food and Drug Administration approved its RSV vaccine, dubbed...
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna pitches RSV shot, new vaccines after ‘difficult year of transition’
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Moderna shares rose by as much as 10% Thursday morning after the COVID-19 vaccine...
Pfizer (PFE), BioNTech Post Data on COVID Jab for Kids Under 5
Zacks via Yahoo Finance· 2 years agoPfizer PFE and partner BioNTech BNTX announced newly-updated data from a phase II/III study,...
Moderna starts application process for RSV vaccine for older adults
Reuters via Yahoo News· 12 months agoIt is aiming to be the third vaccine maker to get an approval in the country after GSK and Pfizer...
FDA greenlights updated mRNA Covid vaccines
Politico via Yahoo News· 9 months agoThe FDA on Monday cleared two updated mRNA Covid-19 shots from Pfizer-BioNTech and Moderna, paving the way for an early fall rollout. It will be the...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 3 weeks agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...
Zacks via Yahoo Finance· 4 months agoFor Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks...
Moderna (MRNA) Beats on Q2 Earnings & Sales, Raises '23 View
Zacks via Yahoo Finance· 11 months agoModerna (MRNA) beats expectations for earnings and sales. Management raises its product revenue...